{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:17:19Z","timestamp":1791296239242,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3723,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/labinvest.2012.129","type":"journal-article","created":{"date-parts":[[2012,9,10]],"date-time":"2012-09-10T08:48:23Z","timestamp":1347266903000},"page":"1574-1582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies"],"prefix":"10.1016","volume":"92","author":[{"given":"Ambrogio","family":"Fassina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maayan","family":"Siri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Zambello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Fassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Simonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Cappellesso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2012.129_bib1","first-page":"3909","volume":"89","year":"1997","journal-title":"A clinical evaluation of the international lymphoma study group classification of non-hodgkin's lymphoma. the non-hodgkin's lymphoma classification project. Blood"},{"key":"10.1038\/labinvest.2012.129_bib2","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","article-title":"The natural history of initially untreated low-grade non-hodgkin's lymphomas","volume":"311","author":"Horning","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2012.129_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1200\/JCO.1983.1.1.11","article-title":"Histologic conversion in the non-hodgkin's lymphomas","volume":"1","author":"Acker","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1038\/labinvest.2012.129_bib4","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2005.02.4786","article-title":"Prognostic biomarkers in diffuse large B-cell lymphoma","volume":"24","author":"Lossos","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1038\/labinvest.2012.129_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1038\/labinvest.2012.129_bib6","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2012.129_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1038\/labinvest.2012.129_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2141.2011.08942.x","article-title":"Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times","volume":"156","author":"Wahlin","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1038\/labinvest.2012.129_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.bjc.6601006","article-title":"Outcome of follicular lymphoma grade 3: Is anthracycline necessary as front-line therapy?","volume":"89","author":"Chau","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1038\/labinvest.2012.129_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.23246","article-title":"Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.","author":"Tada","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1038\/labinvest.2012.129_bib11","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/annonc\/mdl039","article-title":"Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska lymphoma study group experience","volume":"17","author":"Ganti","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1038\/labinvest.2012.129_bib12","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/annonc\/mdq574","article-title":"Follicular non-hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy","volume":"22","author":"Shustik","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1038\/labinvest.2012.129_bib13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3324\/haematol.12754","article-title":"Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas","volume":"93","author":"Piccaluga","year":"2008","journal-title":"Haematologica"},{"issue":"1 Suppl","key":"10.1038\/labinvest.2012.129_bib14","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.bbmt.2011.11.012","article-title":"Follicular lymphoma: prognostic factors, conventional therapies, and hematopoietic cell transplantation","volume":"18","author":"Sehn","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1038\/labinvest.2012.129_bib15","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.3748\/wjg.v17.i48.5231","article-title":"miRNAs in precancerous lesions of the gastrointestinal tract","volume":"17","author":"Fassan","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1038\/labinvest.2012.129_bib16","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2741\/201","article-title":"Role of miRNA in distinguishing primary brain tumors from secondary tumors metastatic to the brain","volume":"3","author":"Fassan","year":"2011","journal-title":"Front BiosciSchol Ed"},{"key":"10.1038\/labinvest.2012.129_bib17","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1582-4934.2008.00628.x","article-title":"Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma","volume":"13","author":"Lawrie","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1038\/labinvest.2012.129_bib18","first-page":"367","article-title":"A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines","volume":"37","author":"Culpin","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1038\/labinvest.2012.129_bib19","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","article-title":"MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas","volume":"142","author":"Roehle","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1038\/labinvest.2012.129_bib20","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1182\/blood-2009-01-202028","article-title":"Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma","volume":"113","author":"Li","year":"2009","journal-title":"Blood"},{"key":"10.1038\/labinvest.2012.129_bib21","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.biocel.2010.02.002","article-title":"MicroRNAs in immune regulation--opportunities for cancer immunotherapy","volume":"42","author":"Okada","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1038\/labinvest.2012.129_bib22","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1158\/0008-5472.CAN-08-1768","article-title":"Emerging role of miR-106b-25\/miR-17-92 clusters in the control of transforming growth factor beta signaling","volume":"68","author":"Petrocca","year":"2008","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2012.129_bib23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.bjc.6605037","article-title":"MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression","volume":"101","author":"Diosdado","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1038\/labinvest.2012.129_bib24","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1158\/0008-5472.CAN-05-2352","article-title":"A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation","volume":"65","author":"Hayashita","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2012.129_bib25","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1158\/0008-5472.CAN-09-1095","article-title":"MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in mantle cell lymphomas","volume":"69","author":"Navarro","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2012.129_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","article-title":"Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes","volume":"9","author":"Xiao","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1038\/labinvest.2012.129_bib27","series-title":"World Health Organisation Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1038\/labinvest.2012.129_bib28","series-title":"Hematopathology","author":"Jaffe","year":"2011"},{"key":"10.1038\/labinvest.2012.129_bib29","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1378\/chest.11-0708","article-title":"Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling","volume":"140","author":"Fassina","year":"2011","journal-title":"Chest"},{"key":"10.1038\/labinvest.2012.129_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/modpathol.2011.144","article-title":"Epithelial-mesenchymal transition in malignant mesothelioma","volume":"25","author":"Fassina","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1038\/labinvest.2012.129_bib31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2007.07.021","article-title":"MiR-150 controls B cell differentiation by targeting the transcription factor c-myb","volume":"131","author":"Xiao","year":"2007","journal-title":"Cell"},{"key":"10.1038\/labinvest.2012.129_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4161\/cbt.7.2.5297","article-title":"miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer","volume":"7","author":"Giannakakis","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1038\/labinvest.2012.129_bib33","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/ijc.25823","article-title":"MicroRNA expression profiling in human barrett's carcinogenesis","volume":"129","author":"Fassan","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1038\/labinvest.2012.129_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.leu.2402002","article-title":"Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK","volume":"15","author":"Kagami","year":"2001","journal-title":"Leukemia"},{"key":"10.1038\/labinvest.2012.129_bib35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2141.2012.09054.x","article-title":"Incidence, risk factors and outcome of histological transformation in follicular lymphoma","volume":"157","author":"Conconi","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1038\/labinvest.2012.129_bib36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V90.1.244","article-title":"Prognostic significance of bcl-2 protein expression and bcl-2 gene rearrangement in diffuse aggressive non-hodgkin's lymphoma","volume":"90","author":"Gascoyne","year":"1997","journal-title":"Blood"},{"key":"10.1038\/labinvest.2012.129_bib37","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1200\/JCO.1996.14.7.2131","article-title":"Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study","volume":"14","author":"Kramer","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1038\/labinvest.2012.129_bib38","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0046-8177(99)90141-7","article-title":"Bcl-6 and bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities","volume":"30","author":"Skinnider","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1038\/labinvest.2012.129_bib39","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1200\/JCO.1988.6.5.919","article-title":"Chromosome studies in the non-hodgkin's lymphomas: the role of the 14;18 translocation","volume":"6","author":"Rowley","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1038\/labinvest.2012.129_bib40","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood.V80.4.879.879","article-title":"Bcl-2 initiates a new category of oncogenes: regulators of cell death","volume":"80","author":"Korsmeyer","year":"1992","journal-title":"Blood"},{"key":"10.1038\/labinvest.2012.129_bib41","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood-2009-01-198580","article-title":"Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations","volume":"114","author":"Leich","year":"2009","journal-title":"Blood"},{"key":"10.1038\/labinvest.2012.129_bib42","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.humpath.2011.05.018","article-title":"Molecular and immunohistochemical characterization of B-cell lymphoma-2-negative follicular lymphomas","volume":"43","author":"Hoeller","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1038\/labinvest.2012.129_bib43","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198904203201605","article-title":"Bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma","volume":"320","author":"Yunis","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2012.129_bib44","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood.V99.7.2285","article-title":"The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile","volume":"99","author":"Huang","year":"2002","journal-title":"Blood"},{"key":"10.1038\/labinvest.2012.129_bib45","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ajh.22099","article-title":"Follicular lymphoma: 2011 update on diagnosis and management","volume":"86","author":"Freedman","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1038\/labinvest.2012.129_bib46","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/path.2586","article-title":"MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets","volume":"219","author":"Baffa","year":"2009","journal-title":"J Pathol"},{"key":"10.1038\/labinvest.2012.129_bib47","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.leukres.2011.06.004","article-title":"The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma","volume":"35","author":"Demirkesen","year":"2011","journal-title":"Leuk Res"},{"key":"10.1038\/labinvest.2012.129_bib48","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene","volume":"435","author":"He","year":"2005","journal-title":"Nature"},{"key":"10.1038\/labinvest.2012.129_bib49","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-03-3773","article-title":"Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma","volume":"64","author":"Ota","year":"2004","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2012.129_bib50","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/gcc.1187","article-title":"Localisation of a novel region of recurrent amplification in follicular lymphoma to an approximately 6.8 mb region of 13q32-33","volume":"32","author":"Neat","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/labinvest.2012.129_bib51","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.ajpath.2011.06.008","article-title":"The miR-17-92 microRNA cluster is regulated by multiple mechanisms in B-cell malignancies","volume":"179","author":"Ji","year":"2011","journal-title":"Am J Pathol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest2012129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2012129","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372200246X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372200246X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2012129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:26:33Z","timestamp":1758396393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002368372200246X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S002368372200246X"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2012.129","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2012.129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}